|
MORC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.585600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.091600E-01 |
| Normal-vs-Stage2 |
1.881370E-01 |
| Normal-vs-Stage3 |
2.429700E-02 |
| Normal-vs-Stage4 |
1.795570E-01 |
| Stage1-vs-Stage2 |
7.669800E-01 |
| Stage1-vs-Stage3 |
1.463170E-01 |
| Stage1-vs-Stage4 |
7.688000E-01 |
| Stage2-vs-Stage3 |
4.677400E-01 |
| Stage2-vs-Stage4 |
9.930400E-01 |
| Stage3-vs-Stage4 |
4.495600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.054200E-01 |
| Normal-vs-AfricanAmerican |
5.222600E-01 |
| Normal-vs-Asian |
6.476600E-01 |
| Caucasian-vs-AfricanAmerican |
8.353600E-01 |
| Caucasian-vs-Asian |
5.280200E-01 |
| AfricanAmerican-vs-Asian |
8.266200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.892830E-01 |
| Normal-vs-Female |
7.322200E-02 |
| Male-vs-Female |
6.029800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.444200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.496400E-02 |
| Normal-vs-Age(61-80Yrs) |
2.019900E-02 |
| Normal-vs-Age(81-100Yrs) |
4.931000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.530600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.636200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.376600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.453000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.995800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.369000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.909030E-01 |
| Classical-VS-Follicular |
7.57070000023674E-08 |
| Classical-VS-Other |
7.849200E-01 |
| Classical-VS-Normal |
6.358400E-01 |
| Tall-VS-Follicular |
6.852100E-02 |
| Tall-VS-Other |
7.380200E-01 |
| Tall-VS-Normal |
1.424410E-01 |
| Follicular-VS-Other |
1.905040E-01 |
| Follicular-VS-Normal |
1.016680E-04 |
| Other-VS-Normal |
6.538200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.015600E-02 |
| Normal-vs-N1 |
3.081200E-01 |
| N0-vs-N1 |
3.770600E-01 |
|
|
